Ralph DeFronzo and his researchers at UT Health at San Antonio announced that they have cured type 1 diabetes.
Read More »Diabetes Risk Reduction Seen with a Digital Health Program, Human Coaching
Study measures effects of apps on weight reduction.
Read More »Resistance Training for Older Adults and Anyone with Reduced Mobility
In addition to aerobic activities, you can greatly improve your blood glucose by doing some resistance, or weight, training. Like so many systems in the body, if you don’t use all your muscle fibers, you lose them over time.
Read More »Optimal BP in Type 2 Diabetes and Kidney Disease
A 62-year-old man presents with type 2 diabetes, hypertension, and albuminuria. His seated BP is 162/104 mm Hg. What's an ideal blood pressure target for this patient? A. 140/90 mm Hg B. 130/80 mm Hg C. 120/70 mm Hg D. 150/80 mm HG Did you get it right? Follow the link to find out!
Read More »Pre-existing Prediabetes
Should prediabetes be considered a pre-existing condition? Follow the link to share your opinion!
Read More »Dealing with Diabetes Burnout
23-year-old female, type 1 diabetes since 5 years of age. A1C elevated to 8.9% after usually having A1Cs in the 6-7 range. Came to see me at the end of our workday after wearing LibrePro (Blinded CGM) to go over her food/insulin/glucose/activity/etc. patterns. First thing she said to me was that she had a Dexcom but hasn't worn it because battery in transmitter was out for the past 6 months. She told me she really hasn't been checking her glucose on a regular basis at all.
Read More »Michael Hill Part 6, Monitoring Adolescents
In part 6 of this Exclusive Interview, understanding how a parent or caregiver can monitor an adolescent who is using the system.
Read More »Insulin & Vascular Function Part 2
In this week's Homerun Slides, the effects of hyperinsulinism.
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #73: Regulation of Glucose Metabolism in Liver Part 9 of 11
Glucose phosphorylation as a therapeutic target for diabetes: Early experiments using genetic overexpression of glucokinase in liver of rodent models showed promise for the protection against hyperglycemia during diabetes, spawning the development of glucokinase activators. These drugs interact with allosteric sites of glucokinase, thus promoting a conformation that exposes the catalytic domain and potentiates the activity of the enzyme.
Read More »Link Between Insulin Resistance and Cognitive Dysfunction
Could diabetes cause increased rates of dementia?
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.